Drug developers will be able to use alternatives to animal testing and possibly get new products to market faster under draft guidance issued Wednesday by the FDA. In a press release, officials said ...
Alternative methods to the use of animals in pharmaceutical testing are becoming more used and accepted. Laura Lotfi of ...
Add Yahoo as a preferred source to see more of our stories on Google. FDA Commissioner Martin Makary on Thursday announced a move away from animal-based drug testing in favor of human-based methods ...
Scrutiny of animal testing's translatability to human outcomes continues to grow within the scientific community. Regulators ...
The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products “with ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...
The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with human-based methods. The agency said the new approach will aim to improve drug ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...
Allied Market Research has published a comprehensive new study titled "Non-Animal Alternative Testing Market by Technology ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued new guidance on how marketing applicants can use non-animal data in their applications. The move comes on the heels of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results